A Randomized Double-Blind Study to Assess the Skin Irritation and Sensitization Potential of Once-Weekly Corplex Donepezil Transdermal Delivery System
Phase of Trial: Phase I
Latest Information Update: 21 Sep 2018
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Corium International
- 13 Sep 2018 Status changed from active, no longer recruiting to completed.
- 16 Jul 2018 Planned End Date changed from 1 May 2018 to 1 Oct 2018.
- 16 Jul 2018 Planned primary completion date changed from 1 May 2018 to 1 Jul 2018.